Paediatric Consumer Health in Brazil

Paediatric consumer health is poised for solid growth in current value terms in Brazil in 2023, maintaining a rate of increase similar to that observed in 2022. While in 2022, in-person schooling exposed children to colds and flu, in 2023, another significant driver of consumption in the category has emerged: cases of arboviruses (dengue, zika, and chikungunya). Dengue cases, in particular, have captured widespread attention in Brazil.

The Paediatric Consumer Health in Brazil report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Nappy (Diaper) Rash Treatments, Paediatric Analgesics, Paediatric Cough, Cold and Allergy Remedies, Paediatric Dermatologicals, Paediatric Digestive Remedies, Paediatric Vitamins and Dietary Supplements.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Paediatric Consumer Health market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.